|
Dieet met voldoende selenium geeft prostaatkanker minder kans
Als mannen ervoor zorgen dat ze voldoende selenium binnenkrijgen, kan hun kans op een dodelijke vorm van prostaatkanker fors afnemen. Dat suggereert een Nederlands onderzoek, dat in 2013 verscheen in de Journal of the National Cancer Institute. In Nederland krijgen, net als in veel andere landen, de meeste mannen minder selenium binnen dan ze volgens voedingswetenschappers nodig hebben.
Studie
Bij 79 procent van de mannen was bekend hoeveel selenium er in hun teennagels zat.
Negenhonderd mannen kregen tijdens de studie een ernstige vorm van prostaatkanker. De onderzoekers vergeleken de seleniumstatus van die mannen met die van mannen die geen prostaatkanker kregen.
Resultaten
Conclusie
"Several studies have provided evidence that the relationship between selenium and cancer may be U-shaped, with a higher risk associated with levels both below and above an optimal selenium range."
"The Nutritional Prevention of Cancer trial showed that selenium supplementation was associated with a reduced risk of total and prostate cancer risk. The association, however, was only present among participants with baseline plasma selenium concentrations in the lowest two tertiles; those in the highest tertile (more than 122 micrograms/l) showed a nonstatistically significant increase in risk." [BJU Int. 2003 May;91(7):608-12] [Cancer Epidemiol Biomarkers Prev. 2002 Jul;11(7):630-9.]
"In our study, quintile medians of toenail selenium ranged from 0.43 to 0.67 micrograms/g. This range of toenail selenium was estimated to be equivalent to (quintile medians) 64 to 100 micrograms/l plasma selenium. Based on results of the Nutritional Prevention of Cancer trial, selenium levels in our study are in the range where additional selenium is expected to be beneficial, in the proposed U-shaped curve."
"In conclusion, our large prospective analysis showed that higher toenail selenium was associated with a substantial decrease in risk of advanced prostate cancer. If our results are confirmed, a prevention trial of selenium and prostate cancer in a low-selenium population may be justified."
Bron: Meer:
|
|